Detailed answers about CAMBRIDGE ANTIBODY TECHNOLOGY GROUP LIMITED, including incorporation, status, business activity, and accounts information.
When was CAMBRIDGE ANTIBODY TECHNOLOGY GROUP LIMITED founded?
CAMBRIDGE ANTIBODY TECHNOLOGY GROUP LIMITED was officially incorporated on 5 August 1996 and is registered under company number 03234033. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is CAMBRIDGE ANTIBODY TECHNOLOGY GROUP LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of CAMBRIDGE ANTIBODY TECHNOLOGY GROUP LIMITED?
CAMBRIDGE ANTIBODY TECHNOLOGY GROUP LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does CAMBRIDGE ANTIBODY TECHNOLOGY GROUP LIMITED do?
CAMBRIDGE ANTIBODY TECHNOLOGY GROUP LIMITED operates in the following sector: 72190 - Other research and experimental development on natural sciences and engineering. This provides insight into the company's primary business activity and industry focus.
What is CAMBRIDGE ANTIBODY TECHNOLOGY GROUP LIMITED's registered address?
The registered office address of CAMBRIDGE ANTIBODY TECHNOLOGY GROUP LIMITED is 1 FRANCIS CRICK AVENUE, CAMBRIDGE BIOMEDICAL CAMPUS, CAMBRIDGE, UNITED KINGDOM, CB2 0AA. This is the official address filed with Companies House for legal and statutory correspondence.
Is CAMBRIDGE ANTIBODY TECHNOLOGY GROUP LIMITED financially stable?
The most recent accounts for CAMBRIDGE ANTIBODY TECHNOLOGY GROUP LIMITED were made up to 31 December 2024, filed as FULL. Next accounts are due by 30 September 2026.